These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 3124306

  • 1. Effect of virucidal heat treatment on proteins in human factor VIII concentrates.
    Thomas KB, McGrath KM, Taylor M, Young IF, Herrington RW, Schiff P.
    Transfusion; 1988; 28(1):8-13. PubMed ID: 3124306
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of the von Willebrand factor in virus inactivated F VIII concentrates: the impact of heat treatment.
    Ingerslev J, Bukh A, Wallevik K, Møller NP, Stenbjerg S.
    Thromb Res; 1987 Jul 15; 47(2):175-82. PubMed ID: 3116714
    [Abstract] [Full Text] [Related]

  • 3. [Study of a therapeutic concentrate of factor VIII/vWf prepared in a closed system].
    Mazurier C, Maillard J, Parquet-Gernez A, Goudemand M.
    Rev Fr Transfus Immunohematol; 1982 Feb 15; 25(1):25-43. PubMed ID: 6803339
    [Abstract] [Full Text] [Related]

  • 4. In vitro characterization of various factor VIII concentrates.
    Yoshioka A, Shima M, Nishino M, Yoshikawa N, Fukui H.
    Arzneimittelforschung; 1987 Jul 15; 37(7):753-6. PubMed ID: 3118888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.
    Clifton JG, Huang F, Kovac S, Yang X, Hixson DC, Josic D.
    Electrophoresis; 2009 Oct 15; 30(20):3636-46. PubMed ID: 19768705
    [Abstract] [Full Text] [Related]

  • 7. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
    Vukovich TC.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Oct 15; 113(6):831-40. PubMed ID: 2436998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of dry heat treatment and anticoagulant on coupling of fibrinogen and fibronectin to von Willebrand factor in normal plasma.
    Ellegård KH, Christiansen K, Ingerslev J.
    Scand J Clin Lab Invest; 1992 Nov 15; 52(7):731-9. PubMed ID: 1333636
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
    Palmer DS, Ganz PR, Perkins H, Rosborough D, Rock G.
    Thromb Haemost; 1990 Jun 28; 63(3):392-402. PubMed ID: 2119525
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Jun 28; 113(5):670-84. PubMed ID: 2435633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the in vitro characteristics of von Willebrand factor in British and commercial factor VIII concentrates.
    Lawrie AS, Harrison P, Armstrong AL, Wilbourn BR, Dalton RG, Savidge GF.
    Br J Haematol; 1989 Sep 28; 73(1):100-4. PubMed ID: 2508742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. von Willebrand factor characterization of a severe dry-heat treated factor VIII concentrate, AHF (high purity).
    Oates A, Polmear E, Herrington R, Farrugia A, Sykes S, Raines G, Aumann H, Street A.
    Thromb Res; 1992 Feb 01; 65(3):389-99. PubMed ID: 1631803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.